| __timestamp | Perrigo Company plc | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 152500000 | 19586000 |
| Thursday, January 1, 2015 | 187800000 | 29135000 |
| Friday, January 1, 2016 | 184000000 | 42791000 |
| Sunday, January 1, 2017 | 167700000 | 49577000 |
| Monday, January 1, 2018 | 218600000 | 89209000 |
| Tuesday, January 1, 2019 | 187400000 | 69099000 |
| Wednesday, January 1, 2020 | 177700000 | 75961000 |
| Friday, January 1, 2021 | 122000000 | 90467000 |
| Saturday, January 1, 2022 | 123100000 | 74552000 |
| Sunday, January 1, 2023 | 122500000 | 91593000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. From 2014 to 2023, Perrigo Company plc and Supernus Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. Perrigo's R&D expenses peaked in 2018, with a notable 43% increase from 2014, before experiencing a gradual decline. In contrast, Supernus Pharmaceuticals has shown a consistent upward trend, with R&D spending surging by an impressive 368% over the same period. This divergence highlights Perrigo's strategic shift towards cost optimization, while Supernus continues to prioritize innovation. As the pharmaceutical industry evolves, these spending patterns may significantly influence each company's market position and product pipeline. Understanding these trends provides valuable insights into the strategic priorities and future potential of these industry players.
Research and Development Investment: Eli Lilly and Company vs Perrigo Company plc
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Perrigo Company plc
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Axsome Therapeutics, Inc. vs Perrigo Company plc
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
R&D Spending Showdown: Perrigo Company plc vs MannKind Corporation
Perrigo Company plc vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.